X-Virus-Scanned: clean according to Sophos on Logan.com Return-Path: Received: from [69.171.58.236] (account marv@lancaironline.net) by logan.com (CommuniGate Pro WebUser 5.0.8) with HTTP id 1027831 for lml@lancaironline.net; Thu, 09 Mar 2006 02:03:29 -0500 From: "Marvin Kaye" Subject: Re: To: lml X-Mailer: CommuniGate Pro WebUser v5.0.8 Date: Thu, 09 Mar 2006 02:03:29 -0500 Message-ID: In-Reply-To: <17E9FE5945A57A41B4D8C07737DB607203725671@PDX-MX6.stoel.com> References: <17E9FE5945A57A41B4D8C07737DB607203725671@PDX-MX6.stoel.com> MIME-Version: 1.0 Content-Type: text/plain; charset="ISO-8859-1"; format="flowed" Content-Transfer-Encoding: 8bit Posted for "Halle, John" : In response to your email below, I am "negative" about only one thing, the assumption that, in switching from the crossbow to the pinpoint product, D2 has solved the AHRS problem. As I have now said several times, I frevently hope that they have solved it. I am only concerned because that conclusion cannot at this point be supported by publicly available empirical fact. To my knowledge, the only empirical difference between the xbow and pinpoint products that is relevant to the question of whether and in what circumstances they work is that, in contrast to the xbow product, the pinpoint product does not have enough use in the field to enable a determination as to what about it, if anything, does not work. When the xbow product was at the same stage of development, those who are now singing the praises of the pinpoint product were singing the praises of the xbow product. It is only the actual use in the field of the xbow product that has identified the problems with the product that now require solution. Given that fact and the fact that it seems clear that actual field testing of products such as both the xbow and the pinpoint AHRS is required to identify and work out the glitches, it seems unduly optimistic to me to assume that the pinpoint product will survive field testing without experiencing similar issues to those experienced by the xbow product. It is possible that I feel this way because I lack access to facts that would reassure me. Among those facts might be the background and experience of those responsible for the pinpoint product or the fact, if true, that the pinpoint product has been extensively field tested. At the moment, the only fact that has been advanced in support of the optimistic assessment of the pinpoint product is that it is not the xbow product. Given the inherent technical challenges associated with produing a low-cost, reliable AHRS that works as advertized without the kind of testing that certification would demand, it simply seems to me that the appropriate attitude about the pinpoint product is to reserve judgment about it until more is known. At that point it may appear that the pinpoint product is more dependable or less dependable than the xbow product. It may ultimately appear that the challenge of building a low-cost, reliable AHRS simply cannot be met; that the price of reliability is not in the four digits but in the five digits. In that case, there is an established, reliable product available from xbow that meets the need. Rather than to speculate on the relative merits of the xbow 400 and the pinpoint products, what I have done to protect myself is to work out a deal with my supplier that, if a switch to the 500 product is necessary, I will get full credit for the price of the 420. That seems to me to be a much safer bet than an unsupported speculation that the pinpoint product will turn out to be reliable from the start without adjustments resulting from field testing. If I had to guess as between the xbow400 and the pinpoint, I would bet on the xbow product for two reasons: first, xbow is an established AHRS manufacturer while, in the absense of any information to the contrary, I must assume that pinpoint is not. Second, one plausible scenario is that both products will eventually be made reliable but only after fixing problems identified in the field. If that is so, one product is not inherently more reliable than the other but xbow is further down the path to establishing the reliability of their product. I stress, however, that this is simply a guess based on the evidence available to me and that I may well be wrong. Unfortunately all of us have to make judgments based on the information available to us and that is all I am doing. I wish I had more information about pinpoint but the fact that I don't seems to be the result of a judgment that they have made about their "business model". As someone who has advised a number of startup companies, I am mystified by a business model that makes a virtue of ignoring the ultimate customer but it's a free country and a market economy and people are at liberty to adopt whatever business model they think will work. The same goes for D2. I don't know what their relationship was with xbow, contractual or other. That is their private affair in which I have no interest (in either sense of the word.) What is public is that, in their press release, they came close to accusing xbow of dishonesty, incompetence or both, an act that, at least from my perspective, seems both imprudent and impolitic for a number of reasons. That said, there may be more to it than I know -- probably is. As it is not up to me to pass judgment on what they did or why they did it, my only intention was to describe what it seemed to me they did. I think that is all that I have done.